IL-6 can suppress synaptic plasticity in hypothalamic arcuate nucleus neurons, reduce the activity of POMC neurons (appetite suppression), and promote the activation of AgRP neurons (appetite promotion), leading to metabolic disorders [67]. The gene discussed is AGRP; the disease is metabolic disease.